Literature DB >> 9763009

Usefulness of CT and MR imaging in the diagnosis of acute Wernicke's encephalopathy.

E Antunez1, R Estruch, C Cardenal, J M Nicolas, J Fernandez-Sola, A Urbano-Marquez.   

Abstract

OBJECTIVE: In this study, we analyzed the sensitivity and specificity of CT and MR imaging in the diagnosis of acute Wernicke's's encephalopathy. SUBJECTS AND METHODS: Three groups of subjects were studied: 15 patients with acute Wernicke's encephalopathy; 15 asymptomatic alcoholics; and 15 control subjects. Studies included clinical and laboratory examinations as well as CT and MR imaging of the brain.
RESULTS: On CT scans, two patients with Wernicke's encephalopathy (13%) and no asymptomatic alcoholics showed low-density abnormalities in the paraventricular regions of the thalamus (p = .2414). On MR imaging, increased T2 signal of paraventricular regions of the thalamus was observed in seven patients (46%) with Wernicke's encephalopathy and one asymptomatic alcoholic (6%) (p < .01), and increased T2 signal of periaqueductal regions of the midbrain in six patients (40%) with Wernicke's encephalopathy and one asymptomatic alcoholic (6%) (p < .05). However, no significant differences were observed in the prevalence of mamillary body shrinkage between alcoholics with Wernicke's encephalopathy (six [40%]) and asymptomatic chronic alcoholics (four [27%]). The sensitivity of MR imaging in revealing evidence of this disease was 53% and the specificity, 93%.
CONCLUSION: MR imaging is useful in confirming the diagnosis of acute Wernicke's encephalopathy. However, the absence of abnormalities on MR imaging does not exclude this diagnosis. CT proved not useful in the diagnosis of Wernicke's encephalopathy.

Entities:  

Mesh:

Year:  1998        PMID: 9763009     DOI: 10.2214/ajr.171.4.9763009

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  76 in total

1.  Wernicke's encephalopathy: atypical manifestation at MR imaging.

Authors:  S J Bae; H K Lee; J H Lee; C G Choi; D C Suh
Journal:  AJNR Am J Neuroradiol       Date:  2001-09       Impact factor: 3.825

2.  Proton MR spectroscopy in Wernicke encephalopathy.

Authors:  Carlos A Rugilo; Marcela C Uribe Roca; Maria C Zurru; Arístides A Capizzano; Gustavo A Pontello; Emilia M Gatto
Journal:  AJNR Am J Neuroradiol       Date:  2003-05       Impact factor: 3.825

3.  Acute bilateral deafness as the first symptom of Wernicke encephalopathy.

Authors:  S-Q Zhang; Y-T Guan
Journal:  AJNR Am J Neuroradiol       Date:  2012-02-02       Impact factor: 3.825

Review 4.  MR imaging of midbrain pathologies.

Authors:  E Hattingen; S Blasel; M Nichtweiss; F E Zanella; S Weidauer
Journal:  Clin Neuroradiol       Date:  2010-06-09       Impact factor: 3.649

Review 5.  Wernicke encephalopathy following splenectomy in a patient with liver cirrhosis: a case report and review of the literature.

Authors:  Xia-ping Zhang; Yuan-qiang Lu; Wei-dong Huang
Journal:  J Zhejiang Univ Sci B       Date:  2010-06       Impact factor: 3.066

Review 6.  Diffusion-weighted imaging of acute excitotoxic brain injury.

Authors:  Toshio Moritani; Wendy R K Smoker; Yutaka Sato; Yuji Numaguchi; Per-Lennart A Westesson
Journal:  AJNR Am J Neuroradiol       Date:  2005-02       Impact factor: 3.825

7.  Prolonged cerebellar ataxia: an unusual complication of hypoglycemia.

Authors:  Jonathan P B Berz; Jay D Orlander
Journal:  J Gen Intern Med       Date:  2007-11-14       Impact factor: 5.128

8.  Advances in dialysis encephalopathy research: a review.

Authors:  Ying Chen; Xin Tian; Xuefeng Wang
Journal:  Neurol Sci       Date:  2018-05-02       Impact factor: 3.307

9.  Wernicke's Encephalopthy Associated with Hyperemesis Gravidarum - A Case Report.

Authors:  Wahinuddin Sulaiman; Azerin Othman; Monniaty Mohamad; Hj Rosemi Salleh; Lily Mushahar
Journal:  Malays J Med Sci       Date:  2002-07

10.  Wernicke's encephalopathy: is diffusion-weighted MRI useful?

Authors:  J Halavaara; A Brander; J Lyytinen; K Setälä; M Kallela
Journal:  Neuroradiology       Date:  2003-07-12       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.